MD News and Press, Mednax Inc. From 12/22/22

Summary Repositioning cross-asset and equity-focused portfolios has been a challenging affair in the latter half of FY22. Such has been the case for longs of MD, where the investment debate how now is negatively skewed to the downside. MD is faced with a series of hurdles to ramp up...

James D. Swift, M.D., Appointed Chief Executive Officer; Mark S. Ordan Appointed Executive Chair of Board of Directors Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, babies and children, today announced that th...

Report outlines the organization’s ESG commitment, vision and strategy Pediatrix® Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, babies and children, today released its inaugural sustainability report which o...

Pediatrix Medical Group, Inc. (NYSE: MD) today announced that it will present on Tuesday, November 8, 2022 at 3:15 p.m. PT to investors attending the Credit Suisse 31 st Annual Healthcare Conference in Rancho Palos Verdes, California. The presentation will be broadcast through live ...

Pediatrix Medical Group, Inc. (MD) Q3 2022 Earnings Conference Call November 3, 2022 9:00 am ET Corporate Participants Charles Lynch - Investor Relations Mark Ordan - Chief Executive Officer Marc Richards - Chief Financial Officer James Swift - Chief Operatin...

Pediatrix Medical Group press release ( NYSE: MD ): Q3 GAAP EPS of $0.37 misses by $0.11 . Revenue of $489.92M (-0.6% Y/Y) misses by $21.54M . Income from continuing operations of $29 million; and Adjusted EBITDA of $58 million. Pediatrix had cash and c...

Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.35 per share for the three months ended September 30, 2022. On a non-GAAP basis, Pedi...

Pediatrix Medical Group ( NYSE: MD ) is scheduled to announce Q3 earnings results on Thursday, November 3rd, before market open. The consensus EPS Estimate is $0.54 (+17.4% Y/Y) and the consensus Revenue Estimate is $511.46M (+3.7% Y/Y). Over the last 2 years, MD has...

Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, November 3, 2022 at 9:00 a.m. ET to discuss results from operations for the quarter ended September 30, 2022. A detailed press release will be issued the morning of November 3, 2022 b...

Summary Pediatrix continues to incur a heavy downside on the chart with the stock down 37% this year to date. Despite the selloff, MD's bottom-line fundamentals continue to look increasingly attractive in the forward-looking investment landscape. In particular recent growth in...